share_log

华熙生物(688363.SH):一季度公司医美业务发展态势良好 仍然保持高速增长

Huaxi Biotech (688363.SH): The company's medical and aesthetic business developed well in the first quarter and maintained rapid growth

Gelonghui Finance ·  May 24 03:33

Gelonghui, May 24 | Huaxi Biotech (688363.SH) said on the investor interactive platform that the company's medical and aesthetic business developed well in the first quarter of 2024 and still maintained rapid growth.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment